Ameritas Investment Partners Inc. decreases the stock position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Ameritas Investment Partners Inc. reduced its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 0.2% in the second quarter, HoldingsChannel.com reports. The firm owned 23,526 shares of the medical equipment provider’s stock after selling 39 shares during the period. Intuitive Surgical comprises 0.6% of Ameritas Investment Partners Inc.’s holdings, making the stock its 28th largest position. The holdings of Ameritas Investment Partners Inc. holdings in Intuitive Surgical were worth $10,465,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in ISRG. Advisors Asset Management Inc. raised its stake in Intuitive Surgical by 18.1% in the first quarter. Advisors Asset Management Inc. now owns 7,380 shares of the medical equipment provider’s stock valued at $2,945,000 after buying an additional 1,129 shares in the last quarter. Public Employees Retirement System of Ohio grew its stake in Intuitive Surgical by 5.4% during the 4th quarter. Public Employees Retirement System of Ohio now owns 191,283 shares of the medical equipment provider’s stock, valued at 64,531. $000,000 after buying an additional 9,869 shares in the last quarter. HCR Wealth Advisors boosted its holdings in shares of Intuitive Surgical by 26.3% during the 4th quarter. HCR Wealth Advisors now owns 1,042 shares of the medical equipment provider’s stock valued at $352,000 after buying an additional 217 shares in the that period. Artisan Partners Limited Partnership increased its position in Intuitive Surgical by 53.5% during the fourth quarter. Artisan Partners Limited Partnership now owns 63,851 shares of the medical equipment provider’s stock valued at $21,541,000 after purchasing an additional 22,264 shares during the last quarter. Finally, SWP Financial LLC bought a new stake in shares of Intuitive Surgical during the 4th quarter valued at about $255,000. Hedge funds and other institutional investors own 83.64% of the company’s shares.

Changes in Analyst Ratings

ISRG has been the subject of several recent research reports. Robert W. Baird upped their target price on shares of Intuitive Surgical from $487.00 to $503.00 and gave the stock an “outperform” rating in a research report on Friday, July 19th. Truist Financial boosted their price objective on Intuitive Surgical from $450.00 to $515.00 and gave the company a “buy” rating in a research note on Tuesday, July 16th. Evercore ISI reduced their price objective on shares of Intuitive Surgical from $425.00 to $410.00 and set an “in-line” rating on the stock in a research report on Friday, July 19th. JPMorgan Chase & Co. boosted their target price on Intuitive Surgical from $475.00 to $495.00 and gave the stock an “overweight” rating in a report on Friday, July 19th. Finally, Goldman Sachs Group began coverage on shares of Intuitive Surgical in a research report on Thursday, May 30th. They set a “buy” rating and a $500.00 price objective on the stock. Six investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average target price of $446.45, according to MarketBeat.com.

Read the latest stock report on ISRG

Insider buying and selling

In other news, SVP Henry L. Charlton sold 40,243 shares of Intuitive Surgical stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $486.84, for a total transaction of $19,591,902.12. Following the sale, the senior vice president now owns 3,001 shares of the company’s stock, valued at approximately $1,461,006.84. The transaction was disclosed in a filing with the SEC, which can be accessed via this link. In related news, EVP Myriam Curet sold 2,818 shares of Intuitive Surgical stock in a transaction on Tuesday, July 23rd. The stock was sold at an average price of $458.13, for a total value of $1,291,010.34. Following the completion of the transaction, the executive vice president now directly owns 298 shares in the company, valued at $136,522.74. The transaction was disclosed in a filing with the SEC, which is available on the SEC’s website. Also, SVP Henry L. Charlton sold 40,243 shares of the stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $486.84, for a total transaction of $19,591,902.12. Following the completion of the sale, the senior vice president now directly owns 3,001 shares in the company, valued at $1,461,006.84. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 53,120 shares of company stock worth $25,528,753. Insiders hold 0.90% of the company’s stock.

Intuitive surgical price performance

Shares of NASDAQ:ISRG opened at $486.20 on Friday. The company’s 50-day moving average price is $468.01 and its 200-day moving average price is $424.86. Intuitive Surgical, Inc. has a 1 year low of $254.85 and a 1 year high of $496.18. The firm has a market cap of $172.46 billion, a PE ratio of 87.76, a P/E/G ratio of 5.41 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG – Get Your Free Report ) last released its earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share for the quarter, topping analysts’ consensus estimates of $1.54 by $0.24. Intuitive Surgical had a net margin of 27.65% and a return on equity of 13.04%. The company had revenue of $2.01 billion for the quarter, compared to analyst estimates of $1.97 billion. In the same period last year, the company posted EPS of $1.18. The company’s revenues increased by 14.5% year-on-year. As a group, analysts expect Intuitive Surgical, Inc. to post 5.22 earnings per share for the current year.

About Intuitive Surgical

(Free Report)

Intuitive Surgical, Inc develops, manufactures and markets products that enable physicians and healthcare providers to improve the quality and access to minimally invasive care in the United States and internationally. The company offers the da Vinci surgical system that enables complex operations using a minimally invasive approach; and the Ion endoluminal system, which expands its commercial offerings beyond surgical interventions in diagnostic procedures that allow minimally invasive biopsies in the lungs.

Further reading

Want to see what other hedge funds hold ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trading for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).

Get news and reviews for Intuitive Surgical Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Intuitive Surgical and related companies with MarketBeat.com ‘s FREE daily email newsletter.